Details for New Drug Application (NDA): 212452
✉ Email this page to a colleague
NDA 212452 describes URSODIOL, which is a drug marketed by Abhai Llc, Amneal Pharms Co, Aurobindo Pharma Ltd, Chartwell Rx, Epic Pharma, Eywa Pharma, Impax Labs Inc, Lannett Co Inc, Lgm Pharma, Mylan, Rising, Rk Pharma, Strides Pharma, Teva Pharms, Zydus, Glenmark Generics, Par Pharm, and Teva Pharms Usa, and is included in twenty-one NDAs. It is available from twenty-seven suppliers. Additional details are available on the URSODIOL profile page.
The generic ingredient in URSODIOL is ursodiol. There are eight drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the ursodiol profile page.
The generic ingredient in URSODIOL is ursodiol. There are eight drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the ursodiol profile page.
Summary for 212452
| Tradename: | URSODIOL |
| Applicant: | Eywa Pharma |
| Ingredient: | ursodiol |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 212452
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| URSODIOL | ursodiol | CAPSULE;ORAL | 212452 | ANDA | Bryant Ranch Prepack | 63629-1173 | 63629-1173-1 | 100 CAPSULE in 1 BOTTLE (63629-1173-1) |
| URSODIOL | ursodiol | CAPSULE;ORAL | 212452 | ANDA | Eywa Pharma Inc | 71930-015 | 71930-015-12 | 100 CAPSULE in 1 BOTTLE (71930-015-12) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 300MG | ||||
| Approval Date: | Oct 30, 2019 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
